Description
Dihexa is a synthetic small-molecule research compound, not a peptide. It is described in supplier and reference databases as an angiotensin IV analog that is orally active and blood-brain barrier permeable, and it has been studied in preclinical research for its interaction with hepatocyte growth factor (HGF)/c-Met signaling and related synaptogenic pathways.
In published animal research, Dihexa has been reported to improve spatial learning and memory in APP/PS1 mice, increase synaptophysin expression, reduce markers of glial activation and inflammation, and activate the PI3K/AKT pathway. These findings are preclinical research observations and should not be presented as established human-use claims.
ATTENTION: All Unique ChemX products featured here are intended exclusively for research and development purposes. They are not designed for any form of human or animal consumption. These products have not undergone evaluation by the U.S. Food and Drug Administration.
